Samsung Electronics is known for its smartphones, TVs and memory chips. Now it wants to tackle biopharmaceuticals, on Friday announcing a new joint venture to produce drugs to treat cancer and arthritis. Here's why the move could prove an ill-needed distraction for the electronics giant.
Pfizer shares were down more than 1% Monday afternoon despite the pharmaceutical giant's report Sunday of successful late-stage trial results for an experimental rheumatoid arthritis drug. The study showed tasocitinib reduced pain and inflammation and improved physical function in patients with moderately to severely active RA.
AstraZeneca and Pozen announced Monday that their pain reliever Vimovo for the treatment of arthritis had received positive agreement for approval by the 23 E.U. nations. Vimovo is a combination drug that reduces the risk of ulcers for frequent NSAID users.
Need an excuse to raise a glass? A new study finds that alcohol may reduce both the severity of rheumatoid arthritis and the risk of getting it in the first place. But don't overdo it: more research is needed, and excessive drinking can do more harm than good.
Pharmaceutical giant Eli Lilly -- maker of Prozac and Cialis -- is expected to post solid fourth-quarter profits on Thursday after a recent restructuring. But the results will likely be lower than the year-ago quarter.
Runners spend $20 billion a year on running shoes, but is all the fancy footwear really a good investment? A new study finds that running shoes exert a lot more stress on key joints than running barefoot, potentially increasing a runner%u2019s risk of developing osteoarthritis.
